文献速递妇科

2019冠状病毒病(COVID-19)大流行下门诊妇科的特殊考量及对未来实践的影响

Special ambulatory gynecologic considerations in the era of coronavirus disease 2019 (COVID-19) and implications for future practice.
PubMed 文献 · Am J Obstet Gynecol · 2020-06-06

本文综述COVID-19大流行期间门诊妇科的重要议题,包括安全与心理健康、生殖生活规划、性传播感染及乳腺癌和宫颈癌常规筛查,讨论如何调整诊疗以确保护理可及性,并探讨未来实践可能的变化。

要点

  • 社交距离要求可能增加亲密伴侣暴力与心理健康风险,影响避孕和堕胎服务可及性。
  • 提倡增加远程医疗服务,使用经验证问卷筛查亲密伴侣暴力和抑郁。
  • 可优先安排长效避孕植入预约,促进患者自控注射避孕和药师提供激素避孕。

核心结论

  • 大流行虽使医疗系统承压,但也为门诊临床医生提供机会,以先前未充分利用的方式扩大对脆弱人群的护理,改善健康公平。

研究设计与样本

  • 本文为综述,回顾门诊妇科重要议题并讨论大流行期间诊疗调整及未来实践变化。

主要发现

  • 社交距离要求可能使患者面临更高亲密伴侣暴力和心理健康问题风险,威胁避孕和堕胎服务的持续可及性,影响孕前规划,中断乳腺癌和宫颈癌常规筛查,增加性传播感染获得风险并减少治疗可及性,加剧既有的种族和少数群体护理与健康结局差异。

关键数值与推荐

  • 提倡增加远程医疗服务,使用经验证问卷增加亲密伴侣暴力和抑郁筛查。
  • 可优先安排长效避孕植入预约。
  • 可促进更容易获得患者自控注射避孕和药师提供的激素避孕。
  • 对于某些符合条件的寻求堕胎患者,可通过减少超声和实验室检测需求确保生殖健康护理可及,药物流产可进行电话随访。
  • 面诊预约应优先给有性传播感染症状的患者,尤其有并发症风险者,同时提供加速伴侣治疗。

临床怎么用

  • 根据作者建议,可增加远程医疗服务并使用经验证问卷筛查亲密伴侣暴力和抑郁。
  • 根据作者建议,可优先安排长效避孕植入预约,促进患者自控注射避孕和药师提供激素避孕。
  • 根据作者建议,对符合条件寻求堕胎的患者可减少超声和实验室检测需求,药物流产可电话随访。
  • 根据作者建议,面诊优先给有性传播感染症状者尤其有并发症风险者,同时提供加速伴侣治疗。
  • 根据作者建议,乳腺癌钼靶筛查和宫颈癌筛查可安全推迟,但高风险人群应参考学会指南建议。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The coronavirus disease 2019 pandemic has altered medical practice in unprecedented ways. Although much of the emphasis in obstetrics and gynecology to date has been on the as yet uncertain effects of coronavirus disease 2019 in pregnancy and on changes to surgical management, the pandemic has broad implications for ambulatory gynecologic care. In this article, we review important ambulatory gynecologic topics such as safety and mental health, reproductive life planning, sexually transmitted infections, and routine screening for breast and cervical cancer. For each topic, we review how care may be modified during the pandemic, provide recommendations when possible on how to ensure continued access to comprehensive healthcare at this time, and discuss ways that future practice may change. Social distancing requirements may place patients at higher risk for intimate partner violence and mental health concerns, threaten continued access to contraception and abortion services, affect prepregnancy planning, interrupt routine screening for breast and cervical cancer, increase risk of sexually transmitted infection acquisition and decrease access to treatment, and exacerbate already underlying racial and minority disparities in care and health outcomes. We advocate for increased use of telemedicine services with increased screening for intimate partner violence and depression using validated questionnaires. Appointments for long-acting contraceptive insertions can be prioritized. Easier access to patient-controlled injectable contraception and pharmacist-provided hormonal contraception can be facilitated. Reproductive healthcare access can be ensured through reducing needs for ultrasonography and laboratory testing for certain eligible patients desiring abortion and conducting phone follow-up for medication abortions. Priority for in-person appointments should be given to patients with sexually transmitted infection symptoms, particularly if at risk for complications, while also offering expedited partner therapy. Although routine mammography screening and cervical cancer screening may be safely delayed, we discuss society guideline recommendations for higher-risk populations. There may be an increasing role for patient-collected human papillomavirus self-samples using new cervical cancer screening guidelines that can be expanded considering the pandemic situation. Although the pandemic has strained our healthcare system, it also affords ambulatory clinicians with opportunities to expand care to vulnerable populations in ways that were previously underutilized to improve health equity.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Cohen MA, Powell AM, Coleman JS, et al. Special ambulatory gynecologic considerations in the era of coronavirus disease 2019 (COVID-19) and implications for future practice. Am J Obstet Gynecol. 2020. PMID: 32522513. doi:10.1016/j.ajog.2020.06.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。